Cargando…

Intervention of Particulate Matter: What Can We Do for Asthmatic Patients?

Detalles Bibliográficos
Autor principal:	Ahn, Kangmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419650/ https://www.ncbi.nlm.nih.gov/pubmed/34486253 http://dx.doi.org/10.4168/aair.2021.13.5.677

Ejemplares similares

We can do much better than what we did
por: Lee, Sang-Hak
Publicado: (2020)

Racism in science: what can we do about it?
Publicado: (2020)

The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)

What Do We Know about Suicide Bereavement, and What We Can Do to Help Suicide-Loss Survivors?
por: Levi-Belz, Yossi, et al.
Publicado: (2023)

Association Between Particulate Matter Oxidative Potential, Oxidative Stress and Inflammation, in Adult Asthmatic Patients. The ASTHMA-FENOP Study
por: Santibáñez, Miguel, et al.
Publicado: (2023)

Obesity and weight management: What can we do as gastroenterologists?
por: Wang, Xia-Qing, et al.
Publicado: (2020)

Gender disparity in scientific publishing: What can we do?
Publicado: (2020)

Oncology nurse: Psychological nursing for cancer patients, what can we do?
por: Lu, Yuhan
Publicado: (2022)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Keeping the Journal in the Second Quarter: What Are We Doing and What Will We Do?
por: Altay, Servet
Publicado: (2023)

Protective Lung Ventilation: What Do We Know?: ‘In An Investigation, Details Matter’
por: Maslow, Andrew, et al.
Publicado: (2023)

Tackling cisplatin resistance in ovarian cancer: what can we do?
por: Perego, Paola
Publicado: (2021)

Phenotyping acute exacerbation of COPD: what more can we do for hospitalised patients?
por: Cen, Lai-Jian, et al.
Publicado: (2021)

Perioperative Care in Patients with Chronic Liver Disease: What Can We Do More?
por: Droc, Gabriela, et al.
Publicado: (2023)

Effects of Airborne Particulate Matter on Respiratory Morbidity in Asthmatic Children
por: Ma, Lu, et al.
Publicado: (2008)

Teleneurorehabilitation in the COVID-19 Era: What Are We Doing Now and What Will We Do Next?
por: Calabrò, Rocco Salvatore
Publicado: (2021)

Effects of Exposure to Indoor Fine Particulate Matter on Atopic Dermatitis in Children
por: Kim, Young-Min, et al.
Publicado: (2021)

COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
por: Ikizler, T. Alp
Publicado: (2020)

Editorial: Occupational Devotion and Lifestyle Entrepreneurship: Doing what we love, loving what we do!
por: Wright, Richard Keith, et al.
Publicado: (2022)

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022)

Monkeypox Outbreaks in Non-Endemic Countries: What Do We Know and What Do We Need?
por: Shamabadi, Ahmad, et al.
Publicado: (2022)

Fine Particulate Matter: a Threat to the Heart Rhythm
por: Ahn, Jinhee
Publicado: (2021)

Has the world ceased to care about HIV? And what can we do about it?
por: Wainberg, Mark A, et al.
Publicado: (2015)

Chronic Kidney Disease—How Does It Go, and What Can We Do and Expect?
por: Chang, Li-Yun, et al.
Publicado: (2023)

Radiation Protection in Cardiovascular Interventions: What Can We Do?
por: Liu, Qiang, et al.
Publicado: (2015)

Why do we Need Quality Articles, What are we Going to do With?
por: Mueen Ahmed, KK
Publicado: (2011)

Why do we grow old: is it because our cells just wear out, we run out of cells (or both), and what can we do about it?
por: Sedivy, John M, et al.
Publicado: (2013)

Bacterial Microbiota of Asthmatic Children and Preschool Wheezers’ Airways—What Do We Know?
por: Bar, Kamil, et al.
Publicado: (2023)

Can We Do More for ISIM?
por: Asscher, A. W., et al.
Publicado: (1979)

Coffee and digestive cancers—what do we know, and where do we go?
por: Loftfield, Erikka, et al.
Publicado: (2020)

Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't
por: Ong, Albert C M, et al.
Publicado: (2022)

Psychological Intervention and COVID-19: What We Know So Far and What We Can Do
por: Inchausti, Felix, et al.
Publicado: (2020)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Medical Students Who Do Not Match to Psychiatry: What Should They Do, and What Should We Do?
por: Balon, Richard, et al.
Publicado: (2020)

The cancer-obesity connection: what do we know and what can we do?
por: Riboli, Elio
Publicado: (2014)

Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020)

Rationing care in COVID-19: if we must do it, can we do better?
por: Rockwood, Kenneth
Publicado: (2020)

Facing the COVID-19 emergency: we can and we do
por: Giovagnoni, Andrea
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4h0uvom6eu06q1caretf4ednvb